Cargando…
Pembrolizumab-Induced Immune-Mediated Glossitis
Pembrolizumab (Keytruda), an anti-PD-1 antibody used in the treatment of several different malignancies has been identified to cause adverse effects pertaining to multiple body systems which include respiratory, gastrointestinal, dermatologic, and endocrine manifestations known as immune-related adv...
Autores principales: | Alias, Alwin, Hall, James A, Kulkarni, Pruthali, Gowan, Alan C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884081/ https://www.ncbi.nlm.nih.gov/pubmed/35242475 http://dx.doi.org/10.7759/cureus.21708 |
Ejemplares similares
-
Radiation Induced Abscopal Effect in a Patient With Malignant Pleural Mesothelioma on Pembrolizumab
por: Rittberg, Rebekah, et al.
Publicado: (2022) -
Acute Glossitis
por: Lewis, James O.
Publicado: (1874) -
Abscopal Effect in a Stage IV Melanoma Patient who Progressed on Pembrolizumab
por: Tsui, James M, et al.
Publicado: (2018) -
Rheumatic Glossitis
Publicado: (1885) -
Hunter's Glossitis
por: Mizumoto, Junki
Publicado: (2020)